Altman Advisors’s Celgene Corp CELG Stock Holding History

Altman Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30,629	Closed	-$2.89M	–	70
2019 Q1	$2.89M	Buy	30,629 +17,634	+136%	+$1.54M	2.66%	3
2018 Q4	$833K	Sell	12,995 -4,516	-26%	-$333K	0.91%	47
2018 Q3	$1.57M	Buy	17,511 +13,711	+361%	+$1.21M	1.41%	43
2018 Q2	$239	Sell	3,800 -12,870	-77%	-$1.07M	0.22%	63
2018 Q1	$1.49M	Buy	16,670 +651	+4%	+$62.5K	1.42%	42
2017 Q4	$1.67M	Buy	+16,019	New	+$1.81M	1.45%	37

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Altman Advisors's CELG Position: Q2 2019 in Review

Altman Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 30,629 shares — an estimated $2.89M sold.

Altman Advisors first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $2.89M in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Altman Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Altman Advisors sold 30,629 Celgene Corp shares in Q2 2019, an estimated $2.89M.
Altman Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
Altman Advisors's Celgene Corp position peaked at $2.89M in Q1 2019.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Altman Advisors's 13F filing for Q2 2019, filed 12 Jul 2019.